(Total Views: 703)
Posted On: 07/29/2020 11:20:28 AM
Post# of 145247
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: MD VIROLOGIST #45650
It is amazing the markets don’t seem to care much about Lenzilumab either. The two most promising therapies still taking a very distant back seat to big pharm meager offerings.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)